Feb 11 (Reuters) - Novo Nordisk said on Wednesday it plans to launch its weight-loss pill Wegovy in vials. "We are exploring ...

‘It’s not an easy pill to take’: The first highly anticipated GLP-1 pill is here, but physicians aren’t sure it has the staying power of the injections ...

By Robin Respaut SAN FRANCISCO, Feb 11 (Reuters) - Among early users of Novo Nordisk'snew Wegovy weight-loss pill, 36% had no ...

Novo Nordisk A/S aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers ...

The oral version of Wegovy has made GLP-1 medicines more accessible and acceptable to many patients who had steered clear of injectable versions, healthcare analytics firm Truveta suggests.

Novo Nordisk CEO Maziar Mike Doustdar acknowledged the market pressure facing the company’s GLP-1 products but sought to ...

The weight-loss drug Wegovy is now being sold in pill form, an advancement that allows users to transition away from weekly injections. It's the first GLP-1 weight-loss medication to become available ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA-approved Wegovy pill is now available for those looking to lose weight. The Wegovy pill was FDA-approved just last month ...

Hims & Hers is rolling out a compounded semaglutide pill at a fraction of the price of Wegovy.

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Hims & Hers has withdrawn its $49 compounded semaglutide pill after pressure from top U.S. health officials at the FDA and ...

Amid the fast-moving rollout of the Wegovy pill, Novo Nordisk has taken to advertising’s biggest stage to help get the word ...